Abstract: Products and methods for treating cancer in a human patient comprising administering to the patient therapeutically effective amount of a first pharmaceutically active agent, wherein the first pharmaceutically active agent is one of an isothiocyanatostilbene and a pharmacologically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, or a combination thereof.
Type:
Grant
Filed:
August 15, 2016
Date of Patent:
April 20, 2021
Assignees:
BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY, BOARD OF SUPERVISORS FOR THE UNIVERSITY OF LOUISIA
Inventors:
Alana Lea Gray, James Cardelli, David Thomas Coleman, Khalid El-Sayed, Mohamed M. Mohyeldin
Abstract: A method for extracting S (-)-Oleocanthal from olive oil comprising mixing a first volume of water with a second volume of olive oil to form an olive oil/water mixture; letting the olive oil/water mixture stand; removing an aqueous fraction from the olive oil/water mixture leaving a reduced S (-)-Oleocanthal containing olive oil; and filtering the aqueous fraction to create aqueous S (-)-Oleocanthal.
Type:
Grant
Filed:
July 21, 2017
Date of Patent:
March 16, 2021
Assignee:
BOARD OF SUPERVISORS FOR THE UNIVERSITY OF LOUISIA
Inventors:
Khalid A. El Sayed, Abu Bakar Siddique, Hassan Y. Ebrahim
Abstract: The chain of events that explains calcitonin receptor (CTR)-stimulated invasion and metastasis of prostate cancer cells was identified. The CTR-stimulated events depend on the interaction of CTR with the PDZ3 domain of ZO-1. Small peptides and small molecules were identified that inhibit this interaction. The small inhibitory peptides were synthesized and can be used to attenuate or inhibit metastasis in solid cancer tumors.
Type:
Application
Filed:
March 30, 2012
Publication date:
September 25, 2014
Applicant:
Board of Supervisors for the University of Louisia System, acting on behalf of the University of Lou